These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10081943)

  • 1. Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease.
    Kropp S; Zerr I; Schulz-Schaeffer WJ; Riedemann C; Bodemer M; Laske C; Kretzschmar HA; Poser S
    Neurosci Lett; 1999 Feb; 261(1-2):124-6. PubMed ID: 10081943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Beaudry P; Cohen P; Brandel JP; Delasnerie-Lauprêtre N; Richard S; Launay JM; Laplanche JL
    Dement Geriatr Cogn Disord; 1999; 10(1):40-6. PubMed ID: 10068257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
    Aksamit AJ; Preissner CM; Homburger HA
    Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease.
    Kohira I; Tsuji T; Ishizu H; Takao Y; Wake A; Abe K; Kuroda S
    Acta Neurol Scand; 2000 Dec; 102(6):385-7. PubMed ID: 11125754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.
    Zerr I; Bodemer M; Räcker S; Grosche S; Poser S; Kretzschmar HA; Weber T
    Lancet; 1995 Jun; 345(8965):1609-10. PubMed ID: 7783539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
    Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
    J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
    Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
    Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
    Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y
    Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
    Sanchez-Juan P; Sánchez-Valle R; Green A; Ladogana A; Cuadrado-Corrales N; Mitrová E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Krasnianski A; Equestre M; Slivarichová D; Saiz A; Calero M; Pocchiari M; Knight R; van Duijn CM; Zerr I
    J Neurol; 2007 Jul; 254(7):901-6. PubMed ID: 17385081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?
    Boesenberg-Grosse C; Schulz-Schaeffer WJ; Bodemer M; Ciesielczyk B; Meissner B; Krasnianski A; Bartl M; Heinemann U; Varges D; Eigenbrod S; Kretzschmar HA; Green A; Zerr I
    BMC Neurol; 2006 Sep; 6():35. PubMed ID: 16989662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.
    Zerr I; Bodemer M; Otto M; Poser S; Windl O; Kretzschmar HA; Gefeller O; Weber T
    Lancet; 1996 Sep; 348(9031):846-9. PubMed ID: 8826809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease.
    Jimi T; Wakayama Y; Shibuya S; Nakata H; Tomaru T; Takahashi Y; Kosaka K; Asano T; Kato K
    Clin Chim Acta; 1992 Oct; 211(1-2):37-46. PubMed ID: 1468153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
    Bahl JM; Heegaard NH; Falkenhorst G; Laursen H; Høgenhaven H; Mølbak K; Jespersgaard C; Hougs L; Waldemar G; Johannsen P; Christiansen M
    Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early elevation of cerebrospinal fluid neuron-specific enolase in Creutzfeldt-Jakob disease.
    Evers S; Droste DW; Lüdemann P; Oberwittler C
    J Neurol; 1998 Jan; 245(1):52-3. PubMed ID: 9457631
    [No Abstract]   [Full Text] [Related]  

  • 20. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Eguchi K; Satoh A; Tsujihata M; Niwa M; Katamine S; Kurihara S; Matsuo H
    Cell Mol Neurobiol; 2006 Feb; 26(1):45-52. PubMed ID: 16633900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.